title: Glial metabotropic glutamate receptor-4 increases maturation and survival of oligodendrocytes.
abstract: Group III metabotropic glutamate (mGlu) receptors mediate important neuroprotective and anti-inflammatory effects. Stimulation of mGlu4 receptor reduces neuroinflammation in a mouse model of experimental autoimmune encephalomyelitis (EAE) whereas mGlu4 knockout mice display exacerbated EAE clinical scores. We now show that mGlu4 receptors are expressed in oligodendrocytes, astrocytes and microglia in culture. Oligodendrocytes express mGlu4 receptors only at early stages of maturation (O4 positive), but not when more differentiated (myelin basic protein, MBP positive). Treatment of immature oligodendrocytes with the mGlu4 receptor agonist L-2-Amino-4-phosphonobutyrate (L-AP4; 50 μM for 48 h) accelerates differentiation with enhanced branching and earlier appearance of MBP staining. Oligodendrocyte death induced by exposure to 1 mM kainic acid for 24 h is significantly reduced by a 30-min pretreatment with L-AP4 (50 μM), an effect observed only in the presence of astrocytes, mimicked by the specific mGlu4 receptor positive allosteric modulator N-Phenyl-7-(hydroxyimino)cyclopropa[b]chromen-1a-carboxamide (PHCCC) (30 μM) and prevented by pretreatment with the mGlu4 receptor antagonist, cyclopropyl-4-phosphonophenylglycine (CPPG) (100 μM). In astrocytes, mGlu4 receptor is the most expressed among group III mGlu receptors, as by Quantitative real time PCR (QRT-PCR), and its silencing prevents protective effects. Protection is also observed when conditioned medium (CM) from L-AP4-pretreated astrocytes is transferred to oligodendrocytes challenged with kainic acid. Transforming growth factor β (TGF-β) mediates the increased oligodendrocyte survival as the effect of L-AP4 is mimicked by addition of 10 ng/ml TGF-β and prevented by incubation with a neutralizing anti-TGF-β antibody. In contrast, despite the expression of mGlu4 receptor in resting and activated microglia, CM from L-AP4-stimulated microglia does not modify kainate-induced oligodendrocyte toxicity. Our results suggest that mGlu4 receptors expressed in astrocytes mediate enhanced survival of oligodendrocytes under conditions of excitotoxicity.
authors: Department of Biomedical and Biotechnological Sciences, Section of Pharmacology, University of Catania Catania, Italy.
authors: Simona Federica
authors: SF
authors: Spampinato
authors: Department of Biomedical and Biotechnological Sciences, Section of Pharmacology, University of Catania Catania, Italy.
authors: Sara
authors: S
authors: Merlo
authors: Department of Biomedical and Biotechnological Sciences, Section of Pharmacology, University of Catania Catania, Italy.
authors: Mariangela
authors: M
authors: Chisari
authors: Department of Physiology and Pharmacology, University of Rome Sapienza Rome, Italy ; IRCSS Neuromed Pozzilli, Italy.
authors: Ferdinando
authors: F
authors: Nicoletti
authors: Department of Biomedical and Biotechnological Sciences, Section of Pharmacology, University of Catania Catania, Italy.
authors: Maria Angela
authors: MA
authors: Sortino
keywords: astrocytes; experimental autoimmune encephalomyelitis; multiple sclerosis; oligodendrocytes; transforming growth factor β
references: Brain Pathol. 2008 Jan;18(1):52-61
references: 17924980
references: J Neurosci Res. 2010 Jun;88(8):1632-44
references: 20091773
references: J Immunol. 1991 Sep 15;147(6):1792-6
references: 1716279
references: J Neuroimmunol. 2005 Jan;158(1-2):182-90
references: 15589052
references: Neuropharmacology. 2014 Jun;81:237-43
references: 24565643
references: Neurochem Int. 2012 Sep;61(4):559-65
references: 22306345
references: J Neuroimmunol. 1993 Aug;47(1):1-7
references: 7690769
references: J Neurosci. 2007 Aug 1;27(31):8297-308
references: 17670976
references: Cytokine Growth Factor Rev. 2006 Feb-Apr;17(1-2):121-8
references: 16271500
references: Glia. 2002 Oct;40(1):95-108
references: 12237847
references: Proc Natl Acad Sci U S A. 2004 May 18;101(20):7751-6
references: 15136737
references: Mult Scler. 1998 Jun;4(3):93-8
references: 9762654
references: Cell Tissue Res. 2008 Dec;334(3):327-38
references: 19002501
references: Nat Med. 2000 Jan;6(1):67-70
references: 10613826
references: J Neurochem. 2005 Feb;92(4):948-61
references: 15686497
references: Neuron. 2003 Dec 18;40(6):1133-45
references: 14687548
references: Microsc Res Tech. 2010 Oct;73(11):1019-29
references: 20232465
references: Neuropharmacology. 2011 Jun;60(7-8):1017-41
references: 21036182
references: Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2918-21
references: 2011600
references: J Neurosci Res. 2006 Aug 1;84(2):268-77
references: 16752416
references: J Neurochem. 2008 Jul;106(1):442-54
references: 18419765
references: Mol Pharmacol. 2012 May;81(5):643-56
references: 22311707
references: J Neurochem. 2012 Apr;121(2):287-301
references: 22243365
references: Mol Pharmacol. 2012 Jan;81(1):12-20
references: 21984253
references: J Neurosci. 1998 Dec 1;18(23):9594-600
references: 9822720
references: J Neurosci. 2003 Mar 15;23(6):2150-60
references: 12657674
references: Eur J Immunol. 2001 Apr;31(4):1132-40
references: 11298338
references: Brain Behav Immun. 2010 May;24(4):641-51
references: 20138983
references: Brain. 2003 Aug;126(Pt 8):1755-66
references: 12805104
references: J Neurochem. 2014 Apr;129(1):4-20
references: 24224472
references: J Clin Invest. 2007 Nov;117(11):3306-15
references: 17965773
references: Neuropharmacology. 2008 Sep;55(4):491-9
references: 18619983
references: Nat Med. 2010 Aug;16(8):897-902
references: 20657581
references: Annu Rev Pharmacol Toxicol. 1997;37:205-37
references: 9131252
references: J Neurosci. 2002 Jul 1;22(13):5403-11
references: 12097492
references: Immunobiology. 2013 Sep;218(9):1192-9
references: 23664544
references: ASN Neuro. 2012 Aug 07;4(5):null
references: 22770428